Skip to main content

FUNCIONES DE LAS MT-MMP DEPENDIENTES DE FLUJO VASCULAR EN CONDICIONES DE SALUD Y ENFERMEDAD 2.0

PID2020-112981RB-I00

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Call year 2020
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Intravascular crawling of patrolling monocytes: a Lèvy-like motility for unique search functions?

  • Moreno-Cañadas, Rocío
  • Luque-Martín, Laura
  • Arroyo, Alicia G.
8p.-1 fig.-1 tab., Patrolling monocytes (PMo) are the organism’s preeminent intravascular guardians by their continuous search of damaged endothelial cells and harmful microparticles for their removal and to restore homeostasis. This surveillance is accomplished by PMo crawling on the apical side of the endothelium through regulated interactions of integrins and chemokine receptors with their endothelial ligands. We propose that the search mode governs the intravascular motility of PMo in vivo in a similar way to T cells looking for antigen in tissues. Signs of damage to the luminal side of the endothelium (local death, oxidized LDL, amyloid deposits, tumor cells, pathogens, abnormal red cells, etc.) will change the diffusive random towards a Lèvy-like crawling enhancing their recognition and clearance by PMo damage receptors as the integrin αMβ2 and CD36. This new perspective can help identify new actors to promote unique PMo intravascular actions aimed at maintaining endothelial fitness and combating harmful microparticles involved in diseases as lung metastasis, Alzheimer’s angiopathy, vaso-occlusive disorders, and sepsis., The work in this manuscript has been funded by the Spanish Ministry of Science and Innovation (grants SAF2017-83229-R and PID2020-112981RB-I00 to AGA and fellowship PRE2018-085163 to LL-M). RM-C has a contract with the Community of Madrid co-financed by the European Social Fund for Youth Employment. We acknowledge support of the publication fee by the CSIC Open Access Publication Support Initiative through its Unit of Information Resources for Research (URICI)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Dynamic expression of membrane type 1-matrix metalloproteinase (Mt1-mmp/Mmp14) in the mouse embryo

  • Muñoz-Sáez, E.
  • Moracho, Natalia
  • Learte, Anabel R.
  • Arroyo, Alicia G.
  • Sánchez-Camacho, Cristina
26 p.-9 fig., MT1-MMP/MMP14 belongs to a subgroup of the matrix metalloproteinases family that presents a transmembrane domain, with a cytosolic tail and the catalytic site exposed to the extracellular space. Deficient mice for this enzyme result in early postnatal death and display severe defects in skeletal, muscle and lung development. By using a transgenic line expressing the LacZ reporter under the control of the endogenous Mt1-mmp promoter, we reported a dynamic spatiotemporal expression pattern for Mt1-mmp from early embryonic to perinatal stages during cardiovascular development and brain formation. Thus, Mt1-mmp shows expression in the endocardium of the heart and the truncus arteriosus by E8.5, and is also strongly detected during vascular system development as well as in endothelial cells. In the brain, LacZ reporter expression was detected in the olfactory bulb, the rostral cerebral cortex and the caudal mesencephalic tectum. LacZ-positive cells were observed in neural progenitors of the spinal cord, neural crest cells and the intersomitic region. In the limb, Mt1-mmp expression was restricted to blood vessels, cartilage primordium and muscles. Detection of the enzyme was confirmed by Western blot and immunohistochemical analysis. We suggest novel functions for this metalloproteinase in angiogenesis, endocardial formation and vascularization during organogenesis. Moreover, Mt1-mmp expression revealed that the enzyme may contribute to heart, muscle and brain throughout development., This research was funded by grants from the UEM (2018UEM13, 2019UEM10) to C.S.-C. and funding from MICINN grants SAF2017-83229-R and PID2020-112981RB-I00 to A.G.A., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

p38 MAPK priming boosts VSMC proliferation and arteriogenesis by promoting PGC1α‑dependent mitochondrial dynamics

  • Sahún-Español, Álvaro
  • Clemente, Cristina
  • Jiménez-Loygorri, Juan Ignacio
  • Sierra-Filardi, Elena
  • Herrera-Melle, Leticia
  • Gómez-Durán, Aurora
  • Sabio, Guadalupe
  • Monsalve, María
  • Boya, Patricia
  • Arroyo, Alicia G.
17 p.-6 fig., Vascular smooth muscle cell (VSMC) proliferation is essential for arteriogenesis to restore blood flow after artery occlusion, but the mechanisms underlying this response remain unclear. Based on our previous findings showing increased VSMC proliferation in the neonatal aorta of mice lacking the protease MT4-MMP, we aimed at discovering new players in this process. We demonstrate that MT4-MMP absence boosted VSMC proliferation in vitro in response to PDGF-BB in a cell-autonomous manner through enhanced p38 MAPK activity. Increased phospho-p38 in basal MT4-MMP-null VSMCs augmented the rate of mitochondrial degradation by promoting mitochondrial morphological changes through the co-activator PGC1α as demonstrated in PGC1α−/− VSMCs. We tested the in vivo implications of this pathway in a novel conditional mouse line for selective MT4-MMP deletion in VSMCs and in mice pre-treated with the p38 MAPK activator anisomycin. Priming of p38 MAPK activity in vivo by the absence of the protease MT4-MMP or by anisomycin treatment led to enhanced arteriogenesis and improved flow recovery after femoral artery occlusion. These findings may open new therapeutic opportunities for peripheral vascular diseases., Funding was provided by the Spanish Ministerio de Ciencia e Innovación (AEI/FEDER, UE), SAF2017-83229-R and PID2020-112981RB-I00 (AGA), PID2020-114709RA-I00 (AGD), PID2019-104399RB-I00 (GS), RTI2018-093864-B-I00 (MM), PGC2018-098557-B-I00 (PB), PRE2019-088222 (JIJL) and the Spanish Ministerio de Educación, Cultura y Deporte, FPU15-05802 (LHM). ASE was supported by fellowships from Obra Social La Caixa, Ford-Apadrina La Ciencia and La Residencia de Estudiantes. AGD is an Atracción de Talento M1 Fellow from Comunidad de Madrid (Spain) [2019-T1BMD-14236]., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Molecular Mechanisms Driven by MT4-MMP in Cancer Progression

  • Muñoz-Sáez, E.
  • Moracho, Natalia
  • Learte, Anabel R.
  • Collignon, Alice
  • Arroyo, Alicia G.
  • Noel, Agnés
  • Sounni, Eddine
  • Sánchez-Camacho, Cristina
MT4-MMP (or MMP-17) belongs to the membrane-type matrix metalloproteinases (MT-MMPs), a distinct subset of the MMP family that is anchored to the cell surface, in this case by a glycosylphosphatidylinositol (GPI) motif. Its expression in a variety of cancers is well documented. However, the molecular mechanisms by which MT4-MMP contributes to tumor development need further investigation. In this review, we aim to summarize the contribution of MT4-MMP in tumorigenesis, focusing on the molecular mechanisms triggered by the enzyme in tumor cell migration, invasiveness, and proliferation, in the tumor vasculature and microenvironment, as well as during metastasis. In particular, we highlight the putative substrates processed and signaling cascades activated by MT4-MMP that may underlie these malignancy processes and compare this with what is known about its role during embryonic development. Finally, MT4-MMP is a relevant biomarker of malignancy that can be used for monitoring cancer progression in patients as well as a potential target for future therapeutic drug development., This research was funded by Universidad Europea de Madrid 2022/UEM07 (EMS, CSC), the National Fund for Scientific Research (FRS-FNRS), Belgium: PDR # T.023020 (NES), and the project PID2020-112981RB-I00 funded by MCIN/AEI/10.13039/501100011033 (AGA)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Capillary pruning couples tissue perfusion and oxygenation with cardiomyocyte maturation in the postnatal mouse heart

  • Santamaría, Ricardo
  • Cruz-Caballero, Javier
  • Gkontra, Polyxeni
  • Jiménez-Montiel, Alberto
  • Clemente, Cristina
  • López, Juan A.
  • Villalba-Orero, María
  • Vázquez, Jesús
  • Hutloff, Andreas
  • Lara-Pezzi, Enrique
  • Arroyo, Alicia G.
19 p.-6 fig., Introduction: Removal of poorly perfused capillaries by pruning contributes to remodeling the microvasculature to optimize oxygen and nutrient delivery. Blood flow drives this process by promoting the intravascular migration of endothelial cells in developing networks, such as in the yolk sac, zebrafish brain or postnatal mouse retina., Methods: In this study, we have implemented innovative tools to recognize capillary pruning in the complex 3D coronary microvasculature of the postnatal mouse heart. We have also experimentally tested the impact of decreasing pruning on the structure and function of this network by altering blood flow with two different vasodilators: losartan and prazosin., Results: Although both drugs reduced capillary pruning, a combination of experiments based on ex vivo imaging, proteomics, electron microscopy and in vivo functional approaches showed that losartan treatment resulted in an inefficient coronary network, reduced myocardial oxygenation and metabolic changes that delayed the arrest of cardiomyocyte proliferation, in contrast to the effects of prazosin, probably due to its concomitant promotion of capillary expansion., Discussion: Our work demonstrates that capillary pruning contributes to proper maturation and function of the heart and that manipulation of blood flow may be a novel strategy to refine the microvasculature and improve tissue perfusion after damage., This work was supported by grants SAF 2017-83229-R funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe” and PID2020-112981RB-I00 funded byMCIN/AEI/10.13039/501100011033 (to AA), Deutsche Forschungsgemeinschaft grant HU 1294/8-1 (to AH)and PGC 2018-097019-B-I00, PID 2021-122348NB-I00, PLEC 2022-009235 and PLEC 2022-009298 from MCIN, P2022/BMD-7333l from CAM and HR17-00247 and HR22-00253 from “La Caixa” Banking Foundation (to JV). RS was a fellow of the FPI Severo Ochoa program CNIC (BES-2016-076636) funded by MCIN/AEI/10.13039/501100011033 and JC-C is a FPI fellow (PRE 2021-099875) funded by MCIN/AEI/10.13039/501100011033 and by “ESF Investing in your future”. CNIC is supported by the MCIN and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (CEX2020-001041-S) funded by MCIN/AEI/10.13039/501100011033., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Tesis doctoral (DoctoralThesis)

Exploring novel regulators of the engulfment of melanoma cells by patrolling monocytes in the lung microvasculature: role of MT4-MMP/αMβ2 integrin axis, Exploración de nuevos reguladores de la ingesta de células de melanoma por monocitos patrulleros en la microvasculatura pulmonar: papel del eje MT4-MMP- integrina αMβ2

  • Luque-Martín, Laura
Tesis Doctoral inédita leída en la Universidad Autónoma de Madrid, Facultad de Medicina, Departamento de Bioquímica. Fecha de Lectura: 29-05-2024.--Programa de Doctorado en Biociencias Moleculares.--169 pag, [EN] Patrolling monocytes (PMo) are a subpopulation of monocytes involved in immune surveillance by their peculiar intravascular crawling on the endothelium searching for harmful micro-particles and promoting their removal. During early lung metastases, PMo scan the microvasculature and engulf tumour cell-derived material reducing metastasis. However, the mechanisms regulating intravascular uptake by PMo remain unclear. Our lab previously found that the protease MT4-MMP can cleave the αM-chain of the αMβ2 integrin, thus regulating PMo crawling on inflamed endothelium and phagocytic activity of PMo-derived macrophages. In the context of experimental lung metastasis in vivo, we have demonstrated that the absence of MT4-MMP during early time points accelerates PMo recruitment and uptake of circulating melanoma cells decreasing the size of melanoma metastatic foci during the first week. This phenomenon can be attributed to MT4-MMP regulatory role over αMβ2 integrin. MT4-MMP absence causes accumulation of αMβ2 integrin in intravascular PMo and αM integrin blockade impaired PMo uptake of melanoma cells, highlighting its role in PMo crawling and engulfment. To further explore the mechanisms regulating intravascular uptake of circulating melanoma cells, we established in vitro triple co-culture assays that revealed that PMo can uptake tumour material from live melanoma cells, reminiscent of trogocytosis. Data from the co-culture assays supported the in vivo findings: the absence of MT4-MMP led to a greater ability of PMo to obtain melanoma membranes by trogocytosis at early timepoints and αMβ2 integrin was involved in this process. In search for novel regulators, we explored the role of Rho GTPases and we observed that they exhibit selectivity in trogocytosis by monocyte subsets as RhoG deletion specifically impacts the trogocytosis of melanoma cells by CMo with no effects in PMo. Moreover, inhibition of the Rho-ROCK pathway in melanoma tumour cells potentially enhanced their susceptibility to be trogocyted by monocytes and macrophages. Taken together, this study reveals that the MT4-MMP/αMβ2 integrin axis is a key regulator of the uptake of circulating melanoma cells by PMo via the novel mechanism of trogocytosis. Furthermore, it suggests the involvement of actin cytoskeleton-related regulators in this process. By integrating these findings with existing knowledge, we may develop potential immunotherapies targeting these pathways to boost PMo intravascular activity and reduce the seeding and spread of metastases, [ES] Los monocitos patrulleros (PMo) son una subpoblación de monocitos que participan en la vigilancia inmunitaria mediante su singular rastreo intravascular sobre el endotelio en busca de micropartículas dañinas, promoviendo su eliminación. Durante los estadios tempranos de metástasis pulmonares, los PMo exploran la microvasculatura y captan material proveniente de células tumorales reduciendo las metástasis. Sin embargo, los mecanismos que regulan la captación intravascular por los PMo todavía no están claros. Nuestro laboratorio descubrió que la proteasa MT4-MMP puede cortar la cadena αM de la integrina αMβ2, regulando así el movimiento de rastreo de PMo sobre el endotelio inflamado y la actividad fagocítica de los macrófagos derivados de PMo. En el contexto de metástasis pulmonar experimental in vivo, se demostró que la ausencia de MT4-MMP acelera el reclutamiento de PMo y la captación de células de melanoma circulantes en estadios tempranos. Además, la ausencia de MT4-MMP provoca la acumulación de la integrina αMβ2 en los PMo intravasculares y el bloqueo de esta integrina afectó a la captación de células de melanoma por PMo, lo que resaltaría su papel en el movimiento de rastreo y en la captación de partículas tumorales por parte de los PMo. Mediante ensayos de triple co-cultivo in vitro hemos explorado los mecanismos de captación intravascular de células circulantes de melanoma y hemos observado que los PMo pueden captar material de células vivas de melanoma, lo que recuerda al proceso de trogocitosis. Estos datos corroboraron los hallazgos observados in vivo: la ausencia de MT4-MMP condujo a una mayor habilidad por parte de los PMo para obtener membranas de melanoma por trogocitosis a tiempos tempranos y la integrina αMβ2 también participó en este proceso. En busca de nuevos reguladores, demostramos la contribución selectiva de las Rho GTPasas: RhoG afecta específicamente a la trogocitosis de células de melanoma por CMo sin efectos en PMo. Además, la inhibición de la vía Rho-ROCK en células tumorales de melanoma aumentaría potencialmente su susceptibilidad a ser trogocitadas por monocitos y macrófagos. En conjunto, este estudio revela que el eje integrina MT4-MMP/αMβ2 es clave en la captación de células circulantes de melanoma por PMo a través del novedoso mecanismo de trogocitosis. Además, sugiere la implicación de reguladores relacionados con el citoesqueleto de actina. Integrando estos hallazgos con el conocimiento existente, podríamos desarrollar posibles inmunoterapias modulando estas rutas para potenciar la actividad intravascular de los PMo y reducir la colonización y diseminación de las metástasis, Este trabajo ha sido financiado con los proyectos del Plan Nacional I+D+I (Ministerio de Economía, Industria y Competitividad): Blood flow-dependent actions of MT-MMPs in health and disease. SAF2017-83229-R. 2018-2020 y Plan Nacional I+D+I (Ministerio de Ciencia e Innovación): Blood flow-dependent actions of MT-MMPs in health and disease 2.0. PID2020-112981RB-I00. 2021-2024., Peer reviewed